Histogenics to serve as shell for Pennsylvania biotech in reverse-me...

04/08/19

Histogenics to serve as shell for Pennsylvania biotech in reverse-merger  Boston Business Journal

Beleaguered cell therapy firm Histogenics Corp. has found a way to avoid bankruptcy or shutting down, announcing Monday that it will be absorbed by a ...

[more]